LEIGHANNE SHIREY: Open Payments
NPI 1922481951 · MARKLEEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 31 payments from 10 companies in 2025. Trend: 2023 $199 · 2024 $268 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $291 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| Exact Sciences Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: VRAYLAR, LEQVIO, TRELEGY ELLIPTA, JOURNAVX, Cologuard Collection Kit, BREZTRI, NEXLETOL, GARDASIL 9.
Industry payments across CA — which companies pay providers there.
